Abstract
Anin vitro system designed to mimic the effect of various plasma nonesterified (polyunsaturated) fatty acids on platelet function and metabolism was employed. Human platelet aggregation induced by submaximal (1.8 μg/ml) collagen stimulation was significantly inhibited by 2 min preincubation with 20 μM albumin-bound docosahexaenoic acid (22∶6n−3) (DHA), but not by the other fatty acids tested. [3H]Phosphatidic acid (PA) formation, an indicator of phospholipase C activation following platelet stimulation, was moderately inhibited by eicosapentaenoic acid (20∶5n−3), 11,14,17-eicosatrienoic acid (20∶3n−3), dihomo-γ-linolenic acid (20∶3n−6), as well as DHA, but not by arachidonic acid (20∶4n−6); this inhibition of phospholipase C activation could not explain the differential effect of DHA on platelet aggregation. The decreased production of thromboxane A2 (TxA2), as assessed by [3H]12-hydroxy-5,8,10-heptadecatrienoic acid (HHT) formation, may account for the inhibition of collagen-induced aggregation by 20 μM DHA. Surprisingly, preincubation with 40 μM albumin-bound DHA, even though resulting in greater inhibition of collagen-induced aggregation, had less impact on HHT formation. A small but significant increase in [3H]prostaglandin D2 (PGD2) levels following 3-min collagen stimulation may have contributed to the greater antiaggregatory effect of 40 μM DHA. It is concluded that increased plasma nonesterified DHA may contribute to the dampened platelet activation and altered metabolism following fish oil supplementation of the diet.
Similar content being viewed by others
Abbreviations
- AA:
-
arachidonic acid
- DG:
-
diacylglycerol
- DHA:
-
docosahexaenoic acid
- EPA:
-
eicosapentaenoic acid
- FFA:
-
free fatty acids
- HETE:
-
hydroxyeicosatetraenoic acid
- HHT:
-
hydroxy-heptadecatrienoic acid
- TP3 :
-
inositol trisphosphate
- NEFA:
-
nonesterified fatty acid
- PA:
-
phosphatidic acid
- PGD2 :
-
prostaglandin D2
- TxA2 :
-
thromboxane A2
- TxB2 :
-
thromboxane B2
References
Dyerberg, J., and Bang, H.O. (1979)Lancet 2, 433–435.
Hirai, A., Hamakazi, T., Terano, T., Nishikawa, T., Tamura, Y., and Kumagai, A. (1980)Lancet 2, 1132–1133.
Kromhout, D., Bosschieter, E.B., and Coulander, L.L. (1985)N. Engl. J. Med. 312, 1205–1209.
Herold, P.M., and Kinsella, J.E. (1986)Am. J. Clin. Nutr. 43, 566–598.
Brox, J.H., Killie, J.E., Gunnes, S., and Nordoy, A. (1981)Thromb. Haemostas 3, 604–611.
Lorenz, R., Spengler, V., Fisher, S., Duhn, J., and Weber, P.C. (1983)Circulation 67, 504–511.
Ahmed, A.A., and Holub, B.J. (1984)Lipids 19, 617–624.
Nordoy, A., Lagarde, M., and Renaud, S. (1984)Eur. J. Clin. Invest. 14, 339–345.
Kondo, T., Ogawa, K., Satake, T., Kitazawa, M., TakI, K., Sugiyana, S., and Ozawa, T. (1986)Clin. Cardiol. 9, 413–416.
Watson, S.P., Reep, B., McConnell, R.T., and Lapetina, E.G. (1985)Biochem. J. 226, 831–837.
Broekman, M.J., Ward, J.W., and Marcus, A.J. (1980)J. Clin. Invest. 66, 275–283.
Berridge, M.J., and Irvine, R.F. (1984)Nature 312, 315–321.
Nishizuka, Y. (1986)Science 233, 305–312.
Billah, M.M., Lapetina, E.G., and Cuatrecasas, P. (1979)Biochem. Biophys. Res. Commun. 90, 92–98.
Brass, L.F., and Laposata, M. (1987)Biochem. Biophys. Res. Commun. 142, 7–14.
Smaal, E.B., Nicolay, K., Mandersloot, J.G., de Gier, J., and de Kruijff (1987)Biochim. Biophys. Acta 897, 453–466.
Kroll, M.H., Zaboico, G.B., and Schafer, A.I. (1989)J. Cell Physiol. 139, 558–564.
Melchert, H.-V., Limsathayourat, N., Mihajilovic, J., Eichberg, W., Thefeld, W., and Roftka, H. (1987)Atherosclerosis 65, 159–166.
Jacobsen, B.K., Trygg, K., Mjermann, I., Thomassen, M.S., Real, C., and Norum, K.R. (1983)Am. J. Clin. Nutr. 38, 906–913.
Mustard, J.F., Perry, D.W., Ardlie, N.G., and Packham, M.A. (1972)Br. J. Haematol. 22, 193–204.
Bligh, D.G., and Dyer, W.J. (1959)Can. J. Biochem. Physiol. 37, 911–917.
Boukhchacke, D., and Lagarde, M. (1982)Biochim. Biophys. Acta 713, 386–392.
Salmon, J.A., and Flower, R.J. (1982)Methods Enzymol. 86, 477–493.
Mitchell, K.T., Ferrell, J.E., Jr., and Huestis, W.H. (1986)Anal. Biochem. 158, 447–453.
Srivastava, K.C. (1985)Prost. Leuk. Med. 17, 319–327.
Rao, G.H.R., Radha, E., and White, J.G. (1983)Biochem. Biophys. Res. Commun. 117 549–555.
Smith, D.L., Willis, A.L., Nguyen, N., Conner, D., Zahkedi, S., and Fulks, J. (1989)Lipids 24, 70–75.
Croset, M., Guichardart, M., and Lagarde, M. (1988)Biochim. Biophys. Acta 961, 252–269.
Fischer, S., von Schacky, C., Siess, W., Strasser, T.H., and Weber, P.C. (1984)Biochem. Biophys. Res. Commun. 120 907–918.
Chen, Z.M., Cerletti, C., de Gaetano, G., and Bertelé, V. (1987)Biochem. Biophys. Res. Commun. 149, 1193–1199.
Silver, M.J., Smith, J.B., Ingerman, C., and Kocsis, J.J. (1973)Prostaglandins 4, 863–875.
Spector, A.A. (1986)Methods Enzymol. 128, 320–329.
Hoak, J.C., Spector, A.A., Fry, G.L., and Barnes, B.C. (1972)Blood 40, 16–22.
Corey, E.J., Shih, C., and Cashman, J.R. (1983)Proc. Natl. Acad. Sci. USA. 80, 3581–3584.
Dratewka-Kos, E., Tinker, D.O., and Kindl, B. (1985)Biochem. Cell Biol. 644, 906–913.
Swann, P.G., Venton, D.L., and LeBreton, G.C. (1988)FEBS Lett. 243, 244–246.
Croset, M., Sala, A., Folco, G., and Lagarde, M. (1988)Biochem. Pharm. 37, 1275–1280.
Watanabe, T., Narumiya, S., Shimizu, T., and Hayaishi, O. (1982)J. Biol. Chem. 257, 14847–14853.
Trist, D.G., Collins, B.A., Wood, J., Kelly, M.G., and Robertson, A.D. (1989)Br. J. Pharmacol. 96, 301–306.
Spence, S., and Houslay, M.D. (1989) Abstract fromBiology of Cellular Transducing Signals '89, Washington, DC, May 1989.
Author information
Authors and Affiliations
About this article
Cite this article
Gaudette, D.C., Holub, B.J. Albumin-bound docosahexaenoic acid and collagen-induced human platelet reactivity. Lipids 25, 166–169 (1990). https://doi.org/10.1007/BF02544332
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02544332